RVMD Earnings

Quarterly EPS
$-0.94
Q3 2024
$-1.12
Q4 2024
$-1.13
Q1 2025
$-1.31
Q2 2025
$-1.61
Q3 2025
$-1.88
Q4 2025
$-2.29
Q1 2026
$-3.06
Q2 2026
Latest RevenueN/A
Latest Net Income-644371000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$3.060-644371000-133.6%
Q1 2026-$2.290-453816000-102.7%
Q4 2025-$1.880-364892000-67.9%
Q3 2025-$1.610-305206000-71.3%
Q2 2025-$1.310-247787000-61.7%
Q1 2025-$1.130-213416000-61.4%
Q4 2024-$1.120-194569000-100.0%+1.8%
Q3 2024-$0.940-156288000+5.1%
Q2 2024-$0.810-133233000
Q1 2024-$0.700-116003000
Q4 2023-$1.14742.0K-161537000
Q3 2023-$0.990-108434000
Revolution Medicines (RVMD) — Earnings